Q1 2020 HTG Molecular Diagnostics Inc Earnings Call Transcript
Greetings and welcome to the HTG Molecular Diagnostics, Inc. First Quarter 2020 Earnings Call. (Operator Instructions)
As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Monique Kosse. Thank you. You may begin.
Thank you, operator. Earlier today, HTG released financial results for the first quarter ended March 31, 2020.
Before we begin the call, let me remind you that the company's remarks include forward-looking statements within the meaning of the federal securities laws including statements regarding expected additional collaborations with pharma customers in 2020, anticipated growth in the company's RUO profiling business and related revenue, expected growth in and benefit from pharma programs and collaborations, product development and commercialization activities.
These forward-looking statements are subject to numerous risks and uncertainties, many of which are beyond HTG's control, including uncertainties regarding the ongoing COVID-19
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |